Bravo González Roberto C, Huwyler Jörg, Boess Franziska, Walter Isabelle, Bittner Beate
Discovery DMPK, F. Hoffmann-La Roche Ltd, Grenzacher Strasse 124, Basel, Switzerland.
Biopharm Drug Dispos. 2004 Jan;25(1):37-49. doi: 10.1002/bdd.383.
The impact of the surface-active formulation ingredients Cremophor EL, Tween 80 and Solutol HS 15 on the intrinsic clearance (Clint) of midazolam (MDZ) was investigated in rat hepatocytes and microsomes. In rat hepatocytes with 0.003%, 0.03% and 0.3% (w/v) Solutol HS 15 already present in the incubation medium, the Clint was significantly reduced in a dose-dependent manner by about 25%, 30% and 50%, respectively. In the presence of Cremophor EL and Tween 80 a significant reduction in Clint by about 30% and 25%, respectively, was observed at 0.03% surfactant concentration. At 0.3% of Cremophor EL and Tween 80, Clint was reduced by about 50% and 20%, respectively. A reduction in Clint was also observed in experiments with rat liver microsomes. At surfactant concentrations up to 0.03%, cytotoxicity assays (lactate dehydrogenase release, adenosine triphosphate content) as well as light microscope investigations did not reveal any cytotoxic impact of the surfactants on the hepatocyte monolayer. A potential interaction of the surfactants with biological membranes was determined using phosphatidylcholine-cholesterol liposomes loaded with self-quenching concentrations of carboxyfluorescein. No marked release of carboxyfluorescein from the liposomes (that would be an indication for a surfactant-dependent disruption of membrane integrity) was observed up to concentrations of 0.03% of the different surfactants. It is concluded that cytochrome P450 3A mediated metabolism of MDZ seems to be prevented by all surfactants at concentrations above 0.03%. In our experiments the surfactants did not show toxic effects at concentrations that resulted in a decreased Clint of MDZ. Thus, a direct inhibition of the metabolizing enzymes, a molecular interaction with the microsomes as well as an alteration of membrane properties that did not yet result in a release of LDH have to be taken into consideration as reasons for the observed changes in the metabolism of MDZ.
研究了表面活性制剂成分聚氧乙烯蓖麻油(Cremophor EL)、吐温80(Tween 80)和聚乙二醇单硬脂酸酯(Solutol HS 15)对大鼠肝细胞和微粒体中咪达唑仑(MDZ)内在清除率(Clint)的影响。在孵育培养基中已含有0.003%、0.03%和0.3%(w/v)Solutol HS 15的大鼠肝细胞中,Clint分别以剂量依赖性方式显著降低约25%、30%和50%。在聚氧乙烯蓖麻油和吐温80存在的情况下,在表面活性剂浓度为0.03%时,观察到Clint分别显著降低约30%和25%。在聚氧乙烯蓖麻油和吐温80浓度为0.3%时,Clint分别降低约50%和20%。在大鼠肝微粒体实验中也观察到Clint降低。在表面活性剂浓度高达0.03%时,细胞毒性试验(乳酸脱氢酶释放、三磷酸腺苷含量)以及光学显微镜检查均未显示表面活性剂对肝细胞单层有任何细胞毒性影响。使用负载有自猝灭浓度羧基荧光素的磷脂酰胆碱 - 胆固醇脂质体测定了表面活性剂与生物膜的潜在相互作用。在不同表面活性剂浓度高达0.03%时,未观察到羧基荧光素从脂质体中明显释放(这表明膜完整性未因表面活性剂而破坏)。得出结论,在浓度高于0.03%时,所有表面活性剂似乎都会阻止细胞色素P450 3A介导的咪达唑仑代谢。在我们的实验中,表面活性剂在导致咪达唑仑Clint降低的浓度下未显示出毒性作用。因此,代谢酶的直接抑制、与微粒体的分子相互作用以及尚未导致乳酸脱氢酶释放的膜性质改变都必须被视为咪达唑仑代谢变化的原因。